Sign in
Taking people in United StatesPhase 1/2

Butyric acid supplement for gut health in young children having heart surgery

Tests butyric acid before heart surgery in babies and toddlers with congenital heart disease.

Key facts

Who runs it
University of Nebraska
Where
Omaha, United StatesSee the site
Trial code
Registry title
Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids
Status
Recruiting
Phase
Phase 1/2
People taking part
105 people, planned
Started
1 Nov 2026
Expected to end
31 Dec 2029
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • 2 mL SunButyrate-TG
  • Placebo
  • 4 mL SunButyrate-TG
Record updated
30 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for infants and young children with congenital heart disease who will have heart surgery using a heart-lung machine (cardiopulmonary bypass). It tests butyric acid (SunButyrate-TG) or a placebo given for 3 weeks before surgery.

Age
1 Month to 3 Years
Sex
All
Disease stage
Congenital heart disease that needs heart surgery with cardiopulmonary bypass.
Earlier treatment
No antibiotics, surgery or chemotherapy in the past 8 weeks.

Main reasons for not taking part

  • Antibiotics, surgery or chemotherapy within the past 8 weeks
  • Continuous tube feeding into the gut before surgery
  • Gut disease or past gut surgery (a G-tube, a feeding tube into the stomach, is allowed)
  • Liver disease with raised liver enzymes
  • Kidney disease that needs dialysis

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Infants and Children undergoing cardiac surgery with cardiopulmonary bypass

Who cannot take part

  • Antibiotics, surgery, or chemotherapy within the past 8 weeks
  • Continuous enteral feeds before surgery
  • GI pathology or intestinal surgery (excluding G-tube)
  • Liver disease with elevated transaminitis or dialysis-dependent renal disease

Where in United States

  • Children's Nebraska, 8200 Dodge StOmaha, United StatesContact: Jeffrey D Salomon, MDTaking people

About the trial

What the trial wants to find out

Butyric acid has been shown to promote gut health and improve the microbiome in multiple adult studies. In preliminary studies in older children with inflammatory bowel disease, butyric acid was shown to be safe. However, it's suitability for infants and young children with congenital heart disease (CHD) has yet to be determined.

Read full original descriptionShow less

This study will examine butyric acid supplementation in infants and children, ages 1 month to 3 years, with CHD who require cardiac surgery with cardiopulmonary bypass. Study goals include determining the safety and tolerability of butyric acid supplementation before cardiac surgery, and to identify changes in gut microbial communities, metabolic profile, and genetic markers intestinal function. Also, the study seeks to establish a reduction in inflammation (inflammatory signaling) after cardiopulmonary bypass (CPB) in participants receiving butyric acid.

The 3 groups in the trial

  • 2 mL SunButyrate-TG (Arm1)Treatment being tested

    Participants will receive 2 milliliter (mL) SunButyrate-TG once daily for 3 weeks prior to cardiac surgery.

    Treatment: 2 mL SunButyrate-TG

  • 4 mL SunButyrate-TG (Arm 2)Treatment being tested

    Participants will receive 4 milliliter (mL) SunButyrate-TG once daily for 3 weeks prior to cardiac surgery.

    Treatment: 4 mL SunButyrate-TG

  • Placebo Comparator (Arm 3)Placebo, for comparison

    Participants will receive either 2 milliliter (mL) or 4 mL of an inactive oil-based placebo once daily for 3 weeks prior to cardiac surgery.

    Treatment: Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids, A Phase IIa Clinical Trial
Plain-language title
Butyric acid supplement for gut health in young children having heart surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
30 October 2026